Serial assessment of endothelial function 1, 6, and 12 months after ST-elevation myocardial infarction

Jasveen J. Kandhai-Ragunath, Carine J.M. Doggen, Liefke C. van der Heijden, Marlies M. Kok, Bjorn de Wagenaar, Cees Doelman, Harald T. Jørstad, Ron J.G. Peters, Clemens von Birgelen* (Corresponding Author), Paolo Zocca

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

37 Downloads (Pure)

Abstract

Knowledge about the changes in endothelial function after ST-elevation myocardial infarction (STEMI) is of substantial interest, but serial data are scarce. The aim of the present study was to noninvasively evaluate whether endothelial function, as assessed shortly after primary percutaneous coronary intervention (PPCI) for STEMI, may improve until 12-month follow-up. This prospective observational cohort study was performed in patients in the RESPONSE randomized trial who participated in a substudy and underwent noninvasive assessment of endothelial function at 1 (baseline), 6, and 12-month follow-up after treatment of a STEMI by PPCI. The reactive hyperemia peripheral artery tonometry (RH-PAT) method was used to assess endothelial function (higher RH-PAT index signifies better function). Of the 70 study participants, who were 57.4 ± 9.7 years of age, 55 (78.6%) were male and 9 (13%) had diabetes. The endothelial function deteriorated significantly during follow-up: the RH-PAT index at baseline, 6, and 12-month follow-up was 1.90 ± 0.58, 1.81 ± 0.57, and 1.69 ± 0.49, respectively (p = 0.04). Although patients were carefully treated in outpatient clinics and adequate pharmacological therapy was prescribed, we noted an increase in total cholesterol (p = 0.001), LDL cholesterol (p = 0.002), HbA1C (p = 0.054), and diastolic blood pressure (p = 0.047) However, multivariate analysis revealed that this increase in cardiovascular risk factors could not explain the observed deterioration in endothelial function. In patients with STEMI, we observed a significant deterioration in endothelial function during 12 months after PPCI that could not be explained by changes in the traditional cardiovascular risk profile.

Original languageEnglish
Pages (from-to)978–985
Number of pages8
JournalHeart and vessels
Volume33
Issue number9
DOIs
Publication statusPublished - Sep 2018

Fingerprint

Hyperemia
Manometry
Percutaneous Coronary Intervention
Arteries
Blood Pressure
Ambulatory Care Facilities
LDL Cholesterol
Observational Studies
Cohort Studies
Multivariate Analysis
Cholesterol
Pharmacology
ST Elevation Myocardial Infarction
Therapeutics

Keywords

  • UT-Hybrid-D
  • Endothelial function
  • Primary PCI
  • Reactive hyperemia peripheral artery tonometry
  • ST-segment elevation myocardial infarction (STEMI)
  • Coronary artery disease

Cite this

Kandhai-Ragunath, J. J., Doggen, C. J. M., van der Heijden, L. C., Kok, M. M., de Wagenaar, B., Doelman, C., ... Zocca, P. (2018). Serial assessment of endothelial function 1, 6, and 12 months after ST-elevation myocardial infarction. Heart and vessels, 33(9), 978–985. https://doi.org/10.1007/s00380-018-1145-1
Kandhai-Ragunath, Jasveen J. ; Doggen, Carine J.M. ; van der Heijden, Liefke C. ; Kok, Marlies M. ; de Wagenaar, Bjorn ; Doelman, Cees ; Jørstad, Harald T. ; Peters, Ron J.G. ; von Birgelen, Clemens ; Zocca, Paolo. / Serial assessment of endothelial function 1, 6, and 12 months after ST-elevation myocardial infarction. In: Heart and vessels. 2018 ; Vol. 33, No. 9. pp. 978–985.
@article{4c3d3e2d97aa4ab792410edbf456ad52,
title = "Serial assessment of endothelial function 1, 6, and 12 months after ST-elevation myocardial infarction",
abstract = "Knowledge about the changes in endothelial function after ST-elevation myocardial infarction (STEMI) is of substantial interest, but serial data are scarce. The aim of the present study was to noninvasively evaluate whether endothelial function, as assessed shortly after primary percutaneous coronary intervention (PPCI) for STEMI, may improve until 12-month follow-up. This prospective observational cohort study was performed in patients in the RESPONSE randomized trial who participated in a substudy and underwent noninvasive assessment of endothelial function at 1 (baseline), 6, and 12-month follow-up after treatment of a STEMI by PPCI. The reactive hyperemia peripheral artery tonometry (RH-PAT) method was used to assess endothelial function (higher RH-PAT index signifies better function). Of the 70 study participants, who were 57.4 ± 9.7 years of age, 55 (78.6{\%}) were male and 9 (13{\%}) had diabetes. The endothelial function deteriorated significantly during follow-up: the RH-PAT index at baseline, 6, and 12-month follow-up was 1.90 ± 0.58, 1.81 ± 0.57, and 1.69 ± 0.49, respectively (p = 0.04). Although patients were carefully treated in outpatient clinics and adequate pharmacological therapy was prescribed, we noted an increase in total cholesterol (p = 0.001), LDL cholesterol (p = 0.002), HbA1C (p = 0.054), and diastolic blood pressure (p = 0.047) However, multivariate analysis revealed that this increase in cardiovascular risk factors could not explain the observed deterioration in endothelial function. In patients with STEMI, we observed a significant deterioration in endothelial function during 12 months after PPCI that could not be explained by changes in the traditional cardiovascular risk profile.",
keywords = "UT-Hybrid-D, Endothelial function, Primary PCI, Reactive hyperemia peripheral artery tonometry, ST-segment elevation myocardial infarction (STEMI), Coronary artery disease",
author = "Kandhai-Ragunath, {Jasveen J.} and Doggen, {Carine J.M.} and {van der Heijden}, {Liefke C.} and Kok, {Marlies M.} and {de Wagenaar}, Bjorn and Cees Doelman and J{\o}rstad, {Harald T.} and Peters, {Ron J.G.} and {von Birgelen}, Clemens and Paolo Zocca",
note = "Springer deal",
year = "2018",
month = "9",
doi = "10.1007/s00380-018-1145-1",
language = "English",
volume = "33",
pages = "978–985",
journal = "Heart and vessels",
issn = "0910-8327",
publisher = "Springer",
number = "9",

}

Kandhai-Ragunath, JJ, Doggen, CJM, van der Heijden, LC, Kok, MM, de Wagenaar, B, Doelman, C, Jørstad, HT, Peters, RJG, von Birgelen, C & Zocca, P 2018, 'Serial assessment of endothelial function 1, 6, and 12 months after ST-elevation myocardial infarction', Heart and vessels, vol. 33, no. 9, pp. 978–985. https://doi.org/10.1007/s00380-018-1145-1

Serial assessment of endothelial function 1, 6, and 12 months after ST-elevation myocardial infarction. / Kandhai-Ragunath, Jasveen J.; Doggen, Carine J.M.; van der Heijden, Liefke C.; Kok, Marlies M.; de Wagenaar, Bjorn; Doelman, Cees; Jørstad, Harald T.; Peters, Ron J.G.; von Birgelen, Clemens (Corresponding Author); Zocca, Paolo.

In: Heart and vessels, Vol. 33, No. 9, 09.2018, p. 978–985.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Serial assessment of endothelial function 1, 6, and 12 months after ST-elevation myocardial infarction

AU - Kandhai-Ragunath, Jasveen J.

AU - Doggen, Carine J.M.

AU - van der Heijden, Liefke C.

AU - Kok, Marlies M.

AU - de Wagenaar, Bjorn

AU - Doelman, Cees

AU - Jørstad, Harald T.

AU - Peters, Ron J.G.

AU - von Birgelen, Clemens

AU - Zocca, Paolo

N1 - Springer deal

PY - 2018/9

Y1 - 2018/9

N2 - Knowledge about the changes in endothelial function after ST-elevation myocardial infarction (STEMI) is of substantial interest, but serial data are scarce. The aim of the present study was to noninvasively evaluate whether endothelial function, as assessed shortly after primary percutaneous coronary intervention (PPCI) for STEMI, may improve until 12-month follow-up. This prospective observational cohort study was performed in patients in the RESPONSE randomized trial who participated in a substudy and underwent noninvasive assessment of endothelial function at 1 (baseline), 6, and 12-month follow-up after treatment of a STEMI by PPCI. The reactive hyperemia peripheral artery tonometry (RH-PAT) method was used to assess endothelial function (higher RH-PAT index signifies better function). Of the 70 study participants, who were 57.4 ± 9.7 years of age, 55 (78.6%) were male and 9 (13%) had diabetes. The endothelial function deteriorated significantly during follow-up: the RH-PAT index at baseline, 6, and 12-month follow-up was 1.90 ± 0.58, 1.81 ± 0.57, and 1.69 ± 0.49, respectively (p = 0.04). Although patients were carefully treated in outpatient clinics and adequate pharmacological therapy was prescribed, we noted an increase in total cholesterol (p = 0.001), LDL cholesterol (p = 0.002), HbA1C (p = 0.054), and diastolic blood pressure (p = 0.047) However, multivariate analysis revealed that this increase in cardiovascular risk factors could not explain the observed deterioration in endothelial function. In patients with STEMI, we observed a significant deterioration in endothelial function during 12 months after PPCI that could not be explained by changes in the traditional cardiovascular risk profile.

AB - Knowledge about the changes in endothelial function after ST-elevation myocardial infarction (STEMI) is of substantial interest, but serial data are scarce. The aim of the present study was to noninvasively evaluate whether endothelial function, as assessed shortly after primary percutaneous coronary intervention (PPCI) for STEMI, may improve until 12-month follow-up. This prospective observational cohort study was performed in patients in the RESPONSE randomized trial who participated in a substudy and underwent noninvasive assessment of endothelial function at 1 (baseline), 6, and 12-month follow-up after treatment of a STEMI by PPCI. The reactive hyperemia peripheral artery tonometry (RH-PAT) method was used to assess endothelial function (higher RH-PAT index signifies better function). Of the 70 study participants, who were 57.4 ± 9.7 years of age, 55 (78.6%) were male and 9 (13%) had diabetes. The endothelial function deteriorated significantly during follow-up: the RH-PAT index at baseline, 6, and 12-month follow-up was 1.90 ± 0.58, 1.81 ± 0.57, and 1.69 ± 0.49, respectively (p = 0.04). Although patients were carefully treated in outpatient clinics and adequate pharmacological therapy was prescribed, we noted an increase in total cholesterol (p = 0.001), LDL cholesterol (p = 0.002), HbA1C (p = 0.054), and diastolic blood pressure (p = 0.047) However, multivariate analysis revealed that this increase in cardiovascular risk factors could not explain the observed deterioration in endothelial function. In patients with STEMI, we observed a significant deterioration in endothelial function during 12 months after PPCI that could not be explained by changes in the traditional cardiovascular risk profile.

KW - UT-Hybrid-D

KW - Endothelial function

KW - Primary PCI

KW - Reactive hyperemia peripheral artery tonometry

KW - ST-segment elevation myocardial infarction (STEMI)

KW - Coronary artery disease

UR - http://www.scopus.com/inward/record.url?scp=85043687145&partnerID=8YFLogxK

U2 - 10.1007/s00380-018-1145-1

DO - 10.1007/s00380-018-1145-1

M3 - Article

AN - SCOPUS:85043687145

VL - 33

SP - 978

EP - 985

JO - Heart and vessels

JF - Heart and vessels

SN - 0910-8327

IS - 9

ER -